|
Volumn 44, Issue 6, 2004, Pages 314-320
|
Cyclin E, p27 and mutant p53 do not predict the prognosis in AJCC stage II colorectal carcinomas.
a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CELL CYCLE PROTEIN;
CYCLIN DEPENDENT KINASE INHIBITOR 1B;
CYCLIN E;
PROTEIN P53;
TUMOR MARKER;
TUMOR SUPPRESSOR PROTEIN;
ADENOCARCINOMA;
ADULT;
AGED;
ARTICLE;
CHEMISTRY;
COLORECTAL TUMOR;
DISEASE FREE SURVIVAL;
FEMALE;
GENETICS;
HUMAN;
IMMUNOHISTOCHEMISTRY;
MALE;
MIDDLE AGED;
MORTALITY;
MUTATION;
PATHOLOGY;
PROGNOSIS;
SURVIVAL RATE;
ADENOCARCINOMA;
ADULT;
AGED;
AGED, 80 AND OVER;
CELL CYCLE PROTEINS;
COLORECTAL NEOPLASMS;
CYCLIN E;
CYCLIN-DEPENDENT KINASE INHIBITOR P27;
DISEASE-FREE SURVIVAL;
FEMALE;
HUMANS;
IMMUNOHISTOCHEMISTRY;
MALE;
MIDDLE AGED;
MUTATION;
PROGNOSIS;
SURVIVAL RATE;
TUMOR MARKERS, BIOLOGICAL;
TUMOR SUPPRESSOR PROTEIN P53;
TUMOR SUPPRESSOR PROTEINS;
|
EID: 18244371085
PISSN: 15989992
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (0)
|